tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form
Company profile
Ticker
THW
Exchange
Website
Employees
Incorporated
Location
SEC CIK
Corporate docs
THW stock data
Latest filings (excl ownership)
N-CEN
Annual report (registered investment company)
12 Dec 23
N-CSR
Certified annual shareholder report (management investment company)
11 Dec 23
DEFA14A
Additional proxy soliciting materials
13 Oct 23
DEFA14A
Additional proxy soliciting materials
5 Oct 23
DEFA14A
Additional proxy soliciting materials
3 Oct 23
DEFA14A
Additional proxy soliciting materials
2 Oct 23
POS EX
Additional exhibits for listing
27 Sep 23
DEFA14A
Additional proxy soliciting materials
15 Sep 23
DEFA14A
Additional proxy soliciting materials
15 Sep 23
DEFA14A
Additional proxy soliciting materials
12 Sep 23
Latest ownership filings
3
Loretta Tse
22 Mar 24
NPORT-P
abrdn World Healthcare Fund (Dec 2023 report)
29 Feb 24
4
Todd Reit
4 Jan 24
3
Ben Ritchie
22 Dec 23
3
Joshua Duitz
22 Dec 23
NPORT-P
Tekla World Healthcare Fund (Sep 2023 report)
15 Nov 23
3
Lucia Sitar
6 Nov 23
3
Alan R Goodson
6 Nov 23
3
Megan Kennedy
6 Nov 23
3
Sharon Ferrari
6 Nov 23
Funds
Series | Ticker | %Monthly Return ? | $Assets | #Holdings | As of | ||
---|---|---|---|---|---|---|---|
Tekla World Healthcare Fund | – | -0.59 | -2.71 | -11.07 | 569.65 mm | 181 | Sep 2023 |
Institutional ownership, Q3 2023
11.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 71 |
Opened positions | 11 |
Closed positions | 6 |
Increased positions | 29 |
Reduced positions | 15 |
13F shares | Current |
---|---|
Total value | 45.17 bn |
Total shares | 4.32 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
MS Morgan Stanley | 947.25 k | $11.10 bn |
RY Royal Bank Of Canada | 547.60 k | $6.42 bn |
UBS UBS Group AG - Registered Shares | 298.18 k | $3.49 bn |
Commonwealth Equity Services | 250.22 k | $2.93 mm |
Advisor | 232.55 k | $2.73 bn |
Steward Partners Investment Advisory | 207.72 k | $2.43 bn |
LPL Financial | 199.57 k | $2.34 bn |
Raymond James & Associates | 157.91 k | $1.85 bn |
Wolverine Asset Management | 132.52 k | $1.55 bn |
Cambridge Investment Research Advisors | 112.81 k | $1.32 mm |
Press releases
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
29 Feb 24
CORRECTION: abrdn U.S. Closed-End Funds Announce Distribution Payment Details
13 Feb 24
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
9 Feb 24
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
31 Jan 24
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
10 Jan 24